The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine recommendations for the 2025-2026 vaccination season.

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its vaccine center

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center that oversees vaccine approvals.